Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: blankmind who wrote (5819)	3/5/1998 9:17:00 AM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

MOUNTAIN VIEW, Calif.--(BW HealthWire)--March 5, 1998--VIVUS, Inc. (NASDAQ:VVUS - news) today announced that a class action lawsuit has been filed in California Superior Court for San Mateo County. The suit names VIVUS and certain senior executives and Board members as defendants and claims violations of the California state securities laws. The suit is filed on behalf of those shareholders who purchased VIVUS stock between May 15, 1997 and Dec. 9, 1997. VIVUS believes the allegations in the lawsuit are without merit and will vigorously defend against this action. Founded in 1991, VIVUS, Inc. is a leader in the development of advanced therapeutic systems for the treatment of erectile dysfunction, commonly referred to as impotence. VIVUS has pioneered a novel therapy for erectile dysfunction known as the transurethral system for erection. This therapy consists of a proprietary, non-invasive drug delivery system that delivers pharmacologic agents via the urethra. ------------------------------------------------------------------------ Contact: VIVUS, Inc. Nina W. Ferrari or David Yntema, 650/934-5200